Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Creative Science, Inc.
WARNING LETTER
•Creative Science, Inc.•March 13, 2017

Creative Science, Inc. – FDA Warning Letter, Mar 13, 2017

Record Details

The FDA conducted an animal drug manufacturing inspection of Creative Science, Inc. from March 6-13, 2017. While initial cGMP violations were addressed, a subsequent review of the firm's website and marketing materials revealed new concerns regarding the product P-Bloc.

The FDA determined that P-Bloc, marketed as a sterile injectable for temporary relief of neurological pain in animals, is an unapproved new animal drug. Evidence includes website claims of providing products to veterinary hospitals for various animal species, sales records showing shipments to animal facilities, and the product label indicating animal use. This violates sections 201(g)(1)(B), 201(v), 512(a), and 501(a)(5) of the FD&C Act, rendering the product unsafe and adulterated.

Furthermore, P-Bloc (NDC 53413-752) was inaccurately listed with the FDA as a "Human Prescription Drug," despite being for animal use. This misrepresentation led to the removal of P-Bloc's listing data from the FDA's online NDC Directory, citing the need for an accurate database to protect public health.

Creative Science, Inc. is required to notify the FDA within fifteen working days of receipt of the letter, outlining steps taken to correct these violations and provide supporting documentation. Failure to comply may result in enforcement actions, including product seizure and/or injunction.

Company
Creative Science, Inc.
Inspection date
March 13, 2017
Product type
Drugs
Office
Detroit District Office
Person
  • Art O. Czabaniuk (Program Division Director)
View Company Profile

ID · c218ba95-2dfd-4701-ad2f-72f864791cb9

Violation Codes10
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(v)21 U.S.C. 360b21 U.S.C. 360ccc21 U.S.C. 360ccc-121 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 U.S.C. 360(j)21 CFR 207.49(a)(8)21 CFR 207

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Creative Science, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.